Biotricity

BTCY · OTC

$0.055+$0.005 (+10.00%)TodayMarket closed ·
Prev close $0.05

Latest news

  • News

    Biotricity Q3 2026 Earnings Call: Complete Transcript

  • Press releaseGlobe Newswire

    Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA

  • News

    Earnings Preview: Biotricity

  • Press releaseGlobe Newswire

    Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th

  • Press releaseGlobe Newswire

    Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026

  • Press releaseGlobe Newswire

    Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th

  • Press releasePRNewswire

    Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users

  • Press releaseGlobe Newswire

    Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins

  • Press releaseGlobe Newswire

    Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th

  • Press releaseGlobe Newswire

    Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach

  • Press releaseGlobe Newswire

    Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

  • Press releaseGlobe Newswire

    Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed

  • Press releasePRNewswire

    Biotricity and B-Secur Partner to Launch the Most Comprehensive Device-Neutral Ambulatory Cardiac Monitoring Platform

  • Press releasePRNewswire

    Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand

  • Press releasePRNewswire

    Biotricity Achieves Positive Free Cash Flow Milestone

  • Press releaseACCESSWIRE

    SWK Holdings Provides Portfolio Update

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.